Pfizer to expand testing Covid-19 vaccine in larger group of children below 12
12:31 | 09/06/2021
On Tuesday, Pfizer said it will testing its COVID-19 vaccine in a larger group of children under age 12, as the vaccine has been authorized for use in children as young as 12 in Europe, the United States and Canada.
Prev Next
Insider
Economy
Bloomberg: Vietnam Sees 2022 Growth Beating Goal as Recovery Powers On
GDP growth quickened to 7.72% in the quarter ended June, beating the government’s 6%-6.5% target.
17:12 | 01/07/2022
